APA (7th ed.) Citation

M, H., FS, F., N, E., C, E., N, D., G, H., & A, K. (2021). Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator. Applied health economics and health policy, 19(1), 57. https://doi.org/10.1007/s40258-020-00571-y

Chicago Style (17th ed.) Citation

M, Hadwiger, Frielitz FS, Eisemann N, Elsner C, Dagres N, Hindricks G, and Katalinic A. "Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator." Applied Health Economics and Health Policy 19, no. 1 (2021): 57. https://doi.org/10.1007/s40258-020-00571-y.

MLA (9th ed.) Citation

M, Hadwiger, et al. "Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator." Applied Health Economics and Health Policy, vol. 19, no. 1, 2021, p. 57, https://doi.org/10.1007/s40258-020-00571-y.